Plasminogen activator inhibitor-1 (PAI-1), a pro-inflammatory cytokine produced by adipocytes and associated with thrombosis and inflammation, represents another adipokine potentially implicated in prostate cancer pathogenesis through effects on angiogenesis, the coagulation cascade, and inflammation. This evidence concerns the gene SERPINE1 and prostate carcinoma.